Shanghai Tofflon Science Tech (300171) - Net Assets

Latest as of September 2025: CN¥8.09 Billion CNY ≈ $1.18 Billion USD

Based on the latest financial reports, Shanghai Tofflon Science Tech (300171) has net assets worth CN¥8.09 Billion CNY (≈ $1.18 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥13.30 Billion ≈ $1.95 Billion USD) and total liabilities (CN¥5.21 Billion ≈ $762.65 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shanghai Tofflon Science Tech (300171) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥8.09 Billion
% of Total Assets	60.81%
Annual Growth Rate	28.47%
5-Year Change	117.84%
10-Year Change	172.95%
Growth Volatility	121.27

Shanghai Tofflon Science Tech - Net Assets Trend (2007–2024)

This chart illustrates how Shanghai Tofflon Science Tech's net assets have evolved over time, based on quarterly financial data. Also explore Shanghai Tofflon Science Tech assets under control for the complete picture of this company's asset base.

Annual Net Assets for Shanghai Tofflon Science Tech (2007–2024)

The table below shows the annual net assets of Shanghai Tofflon Science Tech from 2007 to 2024. For live valuation and market cap data, see Shanghai Tofflon Science Tech market cap and net worth.

Year	Net Assets	Change
2024-12-31	CN¥8.05 Billion ≈ $1.18 Billion	-0.77%
2023-12-31	CN¥8.11 Billion ≈ $1.19 Billion	+6.09%
2022-12-31	CN¥7.64 Billion ≈ $1.12 Billion	+70.69%
2021-12-31	CN¥4.48 Billion ≈ $655.32 Million	+21.24%
2020-12-31	CN¥3.69 Billion ≈ $540.54 Million	+13.92%
2019-12-31	CN¥3.24 Billion ≈ $474.49 Million	+4.02%
2018-12-31	CN¥3.12 Billion ≈ $456.14 Million	+1.01%
2017-12-31	CN¥3.09 Billion ≈ $451.60 Million	+2.88%
2016-12-31	CN¥3.00 Billion ≈ $438.97 Million	+1.76%
2015-12-31	CN¥2.95 Billion ≈ $431.38 Million	+10.14%
2014-12-31	CN¥2.68 Billion ≈ $391.66 Million	+11.15%
2013-12-31	CN¥2.41 Billion ≈ $352.36 Million	+8.13%
2012-12-31	CN¥2.23 Billion ≈ $325.86 Million	+7.12%
2011-12-31	CN¥2.08 Billion ≈ $304.19 Million	+526.20%
2010-12-31	CN¥331.97 Million ≈ $48.58 Million	+56.72%
2009-12-31	CN¥211.83 Million ≈ $31.00 Million	+43.79%
2008-12-31	CN¥147.32 Million ≈ $21.56 Million	+29.58%
2007-12-31	CN¥113.69 Million ≈ $16.64 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Shanghai Tofflon Science Tech's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 4262.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥3.06 Billion	39.14%
Common Stock	CN¥765.83 Million	9.81%
Other Comprehensive Income	CN¥538.05 Million	6.89%
Other Components	CN¥3.45 Billion	44.16%
Total Equity	CN¥7.81 Billion	100.00%

Shanghai Tofflon Science Tech Competitors by Market Cap

The table below lists competitors of Shanghai Tofflon Science Tech ranked by their market capitalization.

Company	Market Cap
Guangdong Tapai Group Co Ltd SHE:002233	$1.47 Billion
Herbalife Nutrition Ltd F:HOO	$1.47 Billion
Grainger PLC F:1U4	$1.47 Billion
Legend Holdings Corporation F:1PC	$1.47 Billion
Shandong Yulong Gold Co Ltd SHG:601028	$1.47 Billion
Blackrock Municipal Target Term Closed Fund NYSE:BTT	$1.47 Billion
YOUZU Interactive Co Ltd SHE:002174	$1.47 Billion
Jiangsu Wujiang Rural Coml Bk SHG:603323	$1.47 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shanghai Tofflon Science Tech's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 7,879,220,430 to 7,805,408,838, a change of -73,811,592 (-0.9%).
Net income of 194,093,228 contributed positively to equity growth.
Dividend payments of 182,334,939 reduced retained earnings.
Share repurchases of 63,943,727 reduced equity.
Other comprehensive income increased equity by 538,053,304.
Other factors decreased equity by 559,679,458.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥194.09 Million	+2.49%
Dividends Paid	CN¥182.33 Million	-2.34%
Share Repurchases	CN¥63.94 Million	-0.82%
Other Comprehensive Income	CN¥538.05 Million	+6.89%
Other Changes	CN¥-559.68 Million	-7.17%
Total Change	CN¥-	-0.94%

Book Value vs Market Value Analysis

This analysis compares Shanghai Tofflon Science Tech's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.25x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 53.30x to 1.25x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2007-12-31	CN¥0.25	CN¥13.12	x
2008-12-31	CN¥0.31	CN¥13.12	x
2009-12-31	CN¥0.44	CN¥13.12	x
2010-12-31	CN¥0.71	CN¥13.12	x
2011-12-31	CN¥3.40	CN¥13.12	x
2012-12-31	CN¥3.53	CN¥13.12	x
2013-12-31	CN¥3.80	CN¥13.12	x
2014-12-31	CN¥4.19	CN¥13.12	x
2015-12-31	CN¥4.60	CN¥13.12	x
2016-12-31	CN¥4.61	CN¥13.12	x
2017-12-31	CN¥4.86	CN¥13.12	x
2018-12-31	CN¥4.72	CN¥13.12	x
2019-12-31	CN¥5.02	CN¥13.12	x
2020-12-31	CN¥5.73	CN¥13.12	x
2021-12-31	CN¥6.79	CN¥13.12	x
2022-12-31	CN¥11.69	CN¥13.12	x
2023-12-31	CN¥10.37	CN¥13.12	x
2024-12-31	CN¥10.46	CN¥13.12	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shanghai Tofflon Science Tech utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.49%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 3.87%
• Asset Turnover: 0.38x
• Equity Multiplier: 1.67x
Recent ROE (2.49%) is below the historical average (16.07%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2007	40.44%	27.49%	0.63x	2.35x	CN¥34.61 Million
2008	37.25%	24.69%	0.60x	2.52x	CN¥39.06 Million
2009	36.65%	24.63%	0.57x	2.60x	CN¥55.17 Million
2010	43.38%	29.72%	0.58x	2.53x	CN¥109.92 Million
2011	10.59%	33.51%	0.26x	1.23x	CN¥12.09 Million
2012	10.65%	28.39%	0.26x	1.47x	CN¥14.29 Million
2013	11.31%	26.09%	0.27x	1.60x	CN¥30.77 Million
2014	12.88%	26.65%	0.30x	1.60x	CN¥75.06 Million
2015	13.47%	24.86%	0.38x	1.41x	CN¥99.60 Million
2016	8.02%	17.66%	0.32x	1.44x	CN¥-57.79 Million
2017	4.12%	7.14%	0.40x	1.46x	CN¥-175.79 Million
2018	2.33%	3.68%	0.41x	1.55x	CN¥-232.11 Million
2019	4.63%	6.44%	0.43x	1.65x	CN¥-169.43 Million
2020	12.86%	17.12%	0.41x	1.83x	CN¥103.15 Million
2021	19.15%	19.74%	0.43x	2.25x	CN¥395.57 Million
2022	11.37%	15.48%	0.41x	1.80x	CN¥102.31 Million
2023	7.62%	10.64%	0.44x	1.64x	CN¥-187.68 Million
2024	2.49%	3.87%	0.38x	1.67x	CN¥-586.45 Million

Industry Comparison

This section compares Shanghai Tofflon Science Tech's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $4,301,461,762
Average return on equity (ROE) among peers: 7.77%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Shanghai Tofflon Science Tech (300171)	CN¥8.09 Billion	40.44%	0.64x	$1.47 Billion
Beijing Centergate Technologies Holding Co Ltd (000931)	$858.96 Million	5.81%	3.43x	$523.48 Million
Blue Sail Medical Co Ltd (002382)	$9.55 Billion	-5.95%	0.64x	$1.10 Billion
Andon Health Co Ltd (002432)	$21.49 Billion	7.76%	0.23x	$5.00 Billion
Allmed Medical Products Co Ltd Class A (002950)	$3.21 Billion	3.44%	0.58x	$1.28 Billion
Guangzhou Improve Med Instrument (300030)	$838.26 Million	3.10%	0.80x	$376.43 Million
QITIAN Technology Group Co Ltd (300061)	$451.92 Million	8.13%	0.70x	$924.78 Million
Truking Technology Ltd (300358)	$1.67 Billion	8.57%	0.72x	$1.02 Billion
Jiangxi Sanxin Medtec Co Ltd (300453)	$122.42 Million	28.61%	0.63x	$770.09 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573)	$520.95 Million	10.42%	0.38x	$2.50 Billion

About Shanghai Tofflon Science Tech

SHE:300171 China Medical Instruments & Supplies

Market Cap

$1.47 Billion

CN¥10.05 Billion CNY

Market Cap Rank

#7468 Global

#1798 in China

Share Price

CN¥13.12

Change (1 day)

-0.53%

52-Week Range

CN¥11.61 - CN¥18.20

All Time High

CN¥59.76